Rapt Therapeutics, Inc. (RAPT)
33.87
+0.49
(+1.47%)
USD |
NASDAQ |
Dec 31, 16:00
33.91
+0.04
(+0.12%)
After-Hours: 20:00
Rapt Therapeutics Research and Development Expense (TTM): 82.87M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Replimune Group, Inc. | 218.21M |
| Olema Pharmaceuticals, Inc. | 146.78M |
| NovaBay Pharmaceuticals, Inc. | -- |
| Palatin Technologies, Inc. | 11.68M |
| Theriva Biologics, Inc. | 10.36M |